Showing results (121-130 of 541) with videos related to

Sort By:
Pageof 55
Drugs - Real World Outcomes|July 6, 2026
Three-Year Interim Results from a Post-Marketing Surveillance Study of Patients with Migraine Treated with Fremanezumab in South KoreaDayoung Seo, Manho Kim, Mi Ji Lee, et al.
Drugs - Real World Outcomes|August 22, 2026
Prospective Real-World Assessment of Pain Relief with Injection-Based Delivery of Etoricoxib (RAPID Study)Shiva Shankar Jha, Anoop Dhamangaonkar, Rajkumar Iyengar, et al.
Drugs - Real World Outcomes|August 29, 2025
Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global StudyApril W Armstrong, Sicily Mburu, George C Gondo, et al.
Drugs - Real World Outcomes|April 28, 2021
Factors Associated with Tramadol Abuse: A Cross-Sectional Study Among Commercial Drivers and Assistants in the Accra Metropolitan Area of GhanaMavis Danso, Francis Anto
Drugs - Real World Outcomes|April 29, 2021
Efficacy of Micronized Purified Flavonoid Fraction-Based Venoactive Therapy After Endovenous Mechanochemical Obliteration: Prospective Comparative StudyVladimir Y Khryshchanovich, Yuri S Nebylitsin, Vladimir A Kosinets
Drugs - Real World Outcomes|May 21, 2021
Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial ProgramPatrick Rossignol, Lea David, Christine Chan, et al.
Drugs - Real World Outcomes|August 29, 2021
Comparison Between Health Insurance Claims and Electronic Health Records (EHRs) for Metastatic Non-small-cell Lung Cancer (NSCLC) Patient Characteristics and Treatment Patterns: A Retrospective Cohort StudyYookyung Christy Choi, Dongmu Zhang, Jerzy E Tyczynski
Drugs - Real World Outcomes|August 23, 2025
Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World StudyRong Fu, Hui Liu, Pin-Tzu Su, et al.
Drugs - Real World Outcomes|May 7, 2020
Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)Joseph Reilly, Micah A Jacobs, Bruce Friedman, et al.
Drugs - Real World Outcomes|May 19, 2021
Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational StudyMikkel Zöllner Ankarfeldt, Janne Petersen, Jon Trærup Andersen, et al.
Pageof 55